Board of Directors

Rich Nazarian, Chief Executive Officer

Rich has more than 20 years of experience in the medical device development field. Prior to founding Minnetronix, he led product development efforts for implantable artificial heart electronic systems, cardiopulmonary bypass systems, laser imaging systems, and other medical and industrial devices for 3M Company. He is a five-time winner of 3M divisional technical excellence awards and a winner of the corporate technical excellence award. Rich is the principal inventor on eight patents ranging from telemetry systems for implantable devices to networked bypass systems. He is the principal author of numerous papers ranging from artificial heart control systems to medical device development methods. Rich holds a Bachelor of Science in Electrical Engineering and a Master of Science in Electrical Engineering from Stanford University.

George Aitken-Davies

George is a co-founder and Managing Director of New York-based investment firm Altaris Capital Partners, LLC, a minority shareholder in Minnetronix. Focused exclusively on the healthcare industry, Altaris invests in businesses that meet clearly defined healthcare needs and leverages its extensive industry knowledge and relationships to accelerate growth and value appreciation. Prior to the formation of Altaris, George held various positions in Merrill Lynch’s private equity and healthcare investment banking groups. He received a Masters in Biochemistry from the University of Oxford and investigated the metabolism of bovine prion protein for his research dissertation at the Università di Padova, Italy. In addition to serving on the Minnetronix Board of Directors, George serves on the Board of Overseers of the Children's Hospital of Philadelphia and as a trustee of the Senator Foundation.

Mark Dankberg

Mark co-founded ViaSat Inc. in 1986 and has been Chairman of the Board and CEO since its inception. Mark was recognized as an Entrepreneur of the Year in San Diego in 2000, as the Satellite Industry Executive of the Year in 2003, and received the American Institute of Aeronautics and Astronautics (AIAA) Aerospace International Communications Award in 2008. An acknowledged industry expert in aerospace, defense and satellite communications, Mark has co-authored several military standards on satellite networking. He holds a number of patents in communications and satellite networking technologies. A participant on Department of Defense advisory panels, Mark was also invited to testify before a congressional committee on high technology growth companies and IPOs. Universities including Rice, NYU, and UC San Diego have invited Mark to speak about communications technology, entrepreneurship, and executive management. He earned a Bachelor of Science in Electrical Engineering and a Master of Science in Electrical Engineering from Rice University and is a member of the Rice University Electrical and Computer Engineering Hall of Fame.

Jack Meyer

Jack has more than 30 years of experience in the medical industry. He has served as CEO of three medical device companies, most recently for Urologix, Inc., a publicly held company, where he was President and CEO. Jack is knowledgeable in medical device development and regulatory approval processes and has worked in both domestic and international markets. He raised over $90 million in two private and two public financings and built strong intellectual property portfolios including over 15 issued and nine licensed patents. Jack developed worldwide reimbursement strategies resulting in an AMA approved CPT procedural code for physician fees, and Medicare reimbursement in 49 states. Jack earned Bachelor of Science and Master of Business Administration degrees from Drake University.

 Mark Wagner

Mark has more than 30 years of global experience in the medical device industry. He served most recently as President and CEO of Minnesota-based Celleration, until its acquisition by Alliqua in May 2015. Prior to Celleration, Mark co-founded and served as board chairman for Orasi Medical, a University of Minnesota spinout developing diagnostic tools for neurological diseases. Additionally, he served as President and CEO for both Reshape Medical and ProVation Medical, and as Chairman and CEO of Survivalink. Mark’s experience also includes a number of executive leadership positions at Nellcor Puritan Bennett. He began his career at GE Healthcare where he worked in marketing, business development and finance. In addition to completing executive leadership and corporate training programs, Mark earned a Bachelor of Science in Business Administration from the University of Southern California.